Benjamin Ediger, Ph.D.
Subscribe to Benjamin Ediger, Ph.D.'s PostsBenjamin (Ben) Ediger, PhD focuses his practice on intellectual property transactions and patent counseling in the life sciences space, along with patent litigation and patent prosecution across a range of diverse technologies. Read Ben Ediger's full bio.
New PTAB Claim Construction? Give the Parties Review Opportunity
By Benjamin Ediger, Ph.D. on Mar 28, 2024
Posted In Patents
The US Patent & Trademark Office (PTO) Director vacated Final Written Decisions issued by the Patent Trial & Appeal Board that presented a sua sponte construction of a claim term in dispute, holding that the parties were not provided adequate notice of the Board’s new construction. Assa Abloy AB v. CPC Patent Technologies Pty., Ltd.,...
Continue Reading
Carolina Calling: Sources of Proof Favor Transfer
By Benjamin Ediger, Ph.D. on Feb 8, 2024
Posted In Patents
The US Court of Appeals for the Federal Circuit vacated a district court order denying transfer, finding that the sources of proof, compulsory process and localized interest factors all favored transfer. In re Honeywell Int’l Inc., Case No. 23-152 (Fed. Cir. Jan. 26, 2024) (Dyk, Bryson, Taranto, JJ.) (per curiam) (nonprecedential) Lone Star SCM Systems...
Continue Reading
Wave Goodbye: Arguments Incorporated by Reference Are Waived
By Benjamin Ediger, Ph.D. on Nov 30, 2023
Posted In Patents
The US Court of Appeals for the Federal Circuit affirmed the Patent Trial & Appeal Board’s patentability determination, finding that the patent challenger waived an argument it attempted to incorporate by reference to another brief. Medtronic, Inc. v. Teleflex Life Scis. Ltd., Case No. 2022-1721 (Fed. Cir. Nov. 16, 2023) (Lourie, Prost, Chen, JJ.) Teleflex...
Continue Reading
Resorting to Extrinsic Evidence Is Necessary When Intrinsic Evidence Is Muddied
By Benjamin Ediger, Ph.D. on Nov 16, 2023
Posted In Patents
The US Court of Appeals for the Federal Circuit determined that the limitation “a pH of 13 or higher” could not be construed using the asserted patents’ intrinsic evidence and therefore remanded to the district court with instructions to consider the extrinsic evidence and its impact on claim construction. Actelion Pharms. Ltd v. Mylan Pharms....
Continue Reading
Go With the Flow: “A” Still Means “One or More”
By Benjamin Ediger, Ph.D. on Oct 26, 2023
Posted In Patents
The US Court of Appeals for the Federal Circuit reversed a claim construction that was adopted during an inter partes review (IPR) because the Patent Trial & Appeal Board erred in construing the contested limitation as limited to a single sample rather than including the possibility of plural samples. ABS Global, Inc. v. Cytonome/ST, LLC,...
Continue Reading
Don’t Ruin Today’s CNS with Yesterday’s Problems
By Benjamin Ediger, Ph.D. on Aug 10, 2023
Posted In Trademarks
The US Court of Appeals for the Fifth Circuit reversed a district court’s trademark invalidity finding based on lack of subject matter jurisdiction because a covenant not to sue (CNS) issued by the trademark owner precluded any reasonably expected future injury that the alleged infringer might incur. Nursery Decals & More, Inc. v. Neat Print,...
Continue Reading
Obviously Prima Facie Case Overcome by Secondary Considerations
By Benjamin Ediger, Ph.D. on Jun 15, 2023
Posted In Patents
The US Court of Appeals for the Federal Circuit affirmed the Patent Trial & Appeal Board, holding that the Board did not err in finding certain challenged claims nonobvious and not unpatentable based on a showing of several objective criteria of nonobviousness and a nexus of the evidence to a commercial product embodying the claimed...
Continue Reading
Actual or Potential Consumers in Related Goods Context Doesn’t Require PURE Overlap
By Benjamin Ediger, Ph.D. on Mar 23, 2023
Posted In Trademarks
The US Court of Appeals for the Federal Circuit reminded us that, in the context of related goods, the likelihood of confusion analysis does not require that actual or potential consumers of the goods be the same, but only that there be sufficient overlap. In re Oxiteno S.A. Industria e Comercio, Case No. 22-1213 (Fed....
Continue Reading
Patent Law Principles Apply to Claim Scope: Orange Book Delisting and Listing and Regulations
By Benjamin Ediger, Ph.D. on Mar 9, 2023
Posted In Patents
The US Court of Appeals for the Federal Circuit ordered that the only Orange Book patent asserted in a lawsuit must be delisted since its claims were directed to the computer-implemented distribution system and not a method of use. Jazz Pharms., Inc. v. Avadel CNS Pharms., LLC, Case No. 23-1186 (Fed. Cir. Feb. 24, 2023)...
Continue Reading
All the Benefits of a Reverse Triangular Merger, None of the IP Merger Mess
By Benjamin Ediger, Ph.D. on Mar 2, 2023
Posted In Uncategorized
The US Court of Appeals for the Eleventh Circuit affirmed a district court’s summary judgment dismissal of plaintiff’s claim that the defendant failed to provide a payment conditioned on the sale, merger or transfer of certain intellectual property since ownership was not transferred via the merger. GSE Consulting, Inc. v. L3Harris Techs., Inc., Case No....
Continue Reading
